Imfinzi Plus Chemotherapy Approved for Advanced Biliary Tract Cancer
The FDA has approved Imfinzi (durvalumab), in combination with gemcitabine and cisplatin, for the treatment of biliary tract cancer.
Source: oncologynurseadvisor.com
Gi Cancer Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Gi Cancer Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Gi Cancer Program Today - Breaking & Trending Today
Imfinzi Plus Chemotherapy Approved for Advanced Biliary Tract Cancer
The FDA has approved Imfinzi (durvalumab), in combination with gemcitabine and cisplatin, for the treatment of biliary tract cancer.
Source: empr.com
IMFINZI® (durvalumab) Plus Chemotherapy Approved in the US as the First Immunotherapy Regimen for Pa
Approval based on TOPAZ-1 Phase III trial results, which showed IMFINZI combination reduced risk of death by 20% vs. chemotherapy aloneWILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s IMFINZI® (durvalumab) has been approved in the US for the treatment of adult patients with locally advanced or metastatic biliary tra...
Source: pharmiweb.com